Oral Pathogens Induce Oral Cancer
Pathogens found in tissues that surround the teeth contribute to a highly aggressive type of oral cancer, according to a multi-institution team of.
Industry News
Industry News
HPV Inhibits the Immune System So HNSCC Tumors Can Grow
Researchers at the University of Michigan School of Dentistry have uncovered how the human papillomavirus (HPV) shuts down the immune system so head and.
Industry News
Radiation and Immunotherapy Combination Shows Promise for HNSCC Treatment
A combination of radiation therapy and immunotherapy may lead to encouraging survival outcomes and acceptable toxicity for patients with locally advanced head and.
Industry News
Checkpoint Inhibitor Increases Head and Neck Cancer Survival Time
The checkpoint inhibitor pembrolizumab (Keytruda) offers patients with advanced head and neck cancers longer survival time, according to researchers led by the Yale.
Industry News
Cigarette Smoke Reprograms Cells to Support Head and Neck Cancer
Cigarette smoke reprograms the cells that surround head and neck squamous cell carcinoma (HNSCC) cells and drives the cancer’s aggressiveness, according to researchers.
Industry News
Aspirin May Save the Lives of Some Head and Neck Cancer Patients
Regular use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may help some patients with head and neck cancer survive the disease, according.
Industry News
Cancer Survival Times Tied to Better Dental Care
Patients with head and neck squamous cell carcinoma (HNSCC) who practice better dental care and consume less alcohol and tobacco have better survival.
Todays Dental News
Q&A: Dr. Jeffrey Myers Investigates Genomic Alterations in Cancer Treatment
Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide, with about 600,000 new cases each year, with 50,000.
